Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

US News & World Report – Genetic Tests Predict Response to Warfarin

Variations of a gene that determines a person’s sensitivity to warfarin are important in determining the initial doses of th

A Tucson-based research institute says it is improving the safety of a widely used blood thinning drug.

Dr. Alastair J.J. Wood, drug development authority, frequent advisor to the Food and Drug Administration (FDA) and former Assistan

The Critical Path Institute today announced that Peter B. Corr, Ph.D., has joined its Board of Directors. Dr. Corr has more than 3

The Critical Path Institute (C-Path) and Ventana Medical Systems, Inc. (Ventana) (NASDAQ: VMSI) today released additional informat

The Critical Path Institute (C-Path) announced the receipt of a $4 million grant from the Agency for Healthcare Research and Quali

Thanks to C-Path’s role as an independent, neutral third party, it has been successful in bringing together scientists from

Science Foundation Arizona (SFAz), through its Strategic Research Group (SRG) program, today announced that it is granting nearly

William Mattes of C-Path spoke at the Arizona Pavillion May 8th 2007 about the Predictive Safety Testing Consortium.

To address the issues surrounding a decade-long decrease in the number of new drug approvals, the U.S. Food and Drug Administratio